About Us

Lepzi Biotechnology Ltd. is an innovative ground for development of high performance technologies for point-of-care medical diagnostics. The LEPZI assay platform developed by our team enables fast, simple and reliable point-of-care testing while addressing the demand for accessible and cost- effective healthcare.

Based in Richmond, Canada, our team brings together professionals with extensive experience in design and development of point-of-care medical devices, from early-stage prototyping and reagent development to implementation of specialized manufacturing and quality control processes.

We strongly believe that quality by design and a solid quality management system coupled with compliance to all applicable standards will contribute to the success of our products.

Our Quality Management System is ISO 13485:2016 registered and it creates a reliable framework for development and manufacture of critical assay components for the LEPZI platform.

The LEPZI assay platform developed by Lepzi Biotechnology Ltd. employs a revolutionary design to provide fast and reliable measurement of specific analytes in human whole blood.

All it takes to run a test is a simple transfer of blood or plasma specimen to the LEPZI test cartridge followed by cartridge scanning inside a portable fluorescence reader.
No sample dilution! No liquid reagents!
  • The utilization of a platform design allows for quick development of new LEPZI tests for a wide range of medical conditions.

  • Our initial portfolio of LEPZI tests includes biomarkers for congestive heart failure, acute myocardial infraction, kidney failure, pulmonary embolism and preeclampsia.

  • New products in development include multiplex LEPZI tests for simultaneous measurement of multiple analytes in a single test cartridge.


In line with our mission to become a global player in the field of point-of-care testing, Lepzi Biotechnology Ltd. seeks opportunities for cooperation with partners who share our vision for innovation and technological advancements in the field of clinical diagnostics.

Our philosophy is that the challenges faced by the healthcare providers worldwide can only be solved by bringing together partners with a diverse expertise in biomarker discovery, clinical research, product development, manufacturing and commercialization.
We envision partnership opportunities in the following areas:
  • LEPZI assay platform licencing to facilitate the introduction of novel biomarkers for medical diagnostics.

  • Distribution partnerships to facilitate the introduction of reliable and cost- effective diagnostic solutions in different parts of the world.

  • Cooperation in building global manufacturing capabilities to address the unique demands of each market.

A great testament of our commitment to excellence is the company’s successful collaboration with Hebei Tewente Biotechnology (Shijiazhuang, China) for commercializing the first generation of assay products for the LEPZI T-Meter I.
SouthEast Asian Healthcare & Pharma Show
9 – 11 April, 2019 – Kuala Lumpur, Malaysia
14 – 17 May, 2019 – Shanghai, China
Expo Hospital
27 – 29 August, 2019 – Santiago, Chile
Lepzi Biotechnology Ltd. is located in Richmond, beautiful British Columbia. With a diverse economy, mild weather and great outdoors this is the place where you will find a perfect balance between working and enjoying life.
Contact Us